Insulin therapy for T1D + T2D Flashcards

(41 cards)

1
Q

Rapid acting insulin analog

  • name
  • method
  • onset of action
  • duration
A

Humalog
Novolog
Glulisine

subcutaneous injxn

onset: 5-15 min,
last 3-5 hrs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

When should you use rapid acting insulin analogs?

A

inject subQ just before a meal to prevent postprandial hyperglycemia

(no adv over IV infusion of recombinant hu insulin)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Short acting human insulin

  • name
  • method
  • onset of action
  • duration
A

Regular insulin
(humulin R, Novolin R)

SubQ or IV

Onset: 30-60 min (IV has immediate effect)
Lasts: 6-8 hours

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

When should you use short acting hu insulin?

A

use 30 min prior to meals,

IV: DKA, hyperosmolar/hyperglycemic state, perioperatively
- has immediate effect

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Long acting insulin analogs

  • name
  • method
  • onset of action
  • duration
A

Glargine
Detemir

Sub Q
Onset: 1.5 hours
Duration: 24 hours

(note: it is injected into the pH neutral SubQ even though it is acidic, bc that is what gives it the slow release)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

When should you give long acting insulin?

A

once a day to provide basal coverage

*note: acid pH, cannot be mixed with other insulins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Intermediate acting insulins

  • name
  • method
  • onset of action
  • duration
A

NPH, Humulin N, Novolin N.

*cloudy

SubQ

Onset: 1-3 Hrs
Duration: 12-16 hoursd

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

When should you give intermediate acting insulins?

A

NPH used to treat mid day hyperglycemia associated with lunch, and to act as a basal insulin

  • twice daily injxns
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Bolus insulin made up of?

A

Prandial and correctional insulin doses

- pts on this are on the “basal bolus therapy”

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Basal insulins you can use

A

glargine
Detemir
NPH

(without this, pts with T1D can get DKA, and T2D can get severe hyperglycemia)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Prandial insulins you can use

A

humalog
novolog
apidra

*same same for correctional

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Correctional doses of insulin you can use

A

Humalog
novolog
apidra

*same for prandial insulins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Ratio of number of grams of carbs that 1 unit of insulin is anticipated to cover

A

C:I
15:1 or 20:1

(insulin R indiv are 10:1)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

How many KCal/g is in carbs and fat

A

Carbs: 4KCal/g
Fat: 9KCal/g

(average expenditure is 30KCal/kg/day)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

dawn phenomenon

A

hyperglycemia in response to surge in growth hormon/cortisol (CRH)

  • give them a bit more insulin (0.9 units/hr instead of 0.6 in between 4am-8am)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

LDL = ?

A

TC - HDL - (TG/5)

TG/5 is estimate of VLDL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

early morning hyperglycemia can be due to?

A

Clinical pearls

  1. inadequate basal insulin dosing
  2. bedtime hyperglycemia
  3. waning effect of basal insulin
  4. somogyi effect
18
Q

Somogyi effect

A

nocturnal hypoglycemia causing a surge of CRH –>
morning hyperglycemia

*dawn phenom: surge of GH

19
Q

preferred method for achieving control of inpatient hyperglycemia

A

insulin therapy

- discontinue oral agents at time of hospital admission

20
Q

INsulin secretagogues

- action

A

sulfonureas

  • enhance endogenous insulin by increasing b cell secretion by closing ATP sensitive K channels in membrane . . . yadi yada
21
Q

side effects of sulfonureas

A

hypoglycemia

weight gain

22
Q

Metformin

- action

A

acts at liver to potentiate effects of insulin on glucose production
(helps insulin)

  • does not stimulate insuling secretion (sulfonureas)
23
Q

Side effects of metformin

A

GI:
n/v
bloating
diarrhea

-lactic acidosis if they are at higher risk

on plus side, thanx to that, NO weight gain! NO hypoglycemia when used as monotherapy

24
Q

Contraindications to metformin use

A
  • CHF
  • IV iodinated contrast media
  • Renal impairment
  • met acidosis
25
Thiazolidinediones (TZDs)
true insulin sensitizers that enhance insulin action at level of skeletal m and adipose tissue - binding of TZD to PPAR-y receptor
26
side effects of Thiazolidinediones (TZDs)
fluid retention/edema hemodilution exacerbation of HF
27
contraindications for TZDs
- active liver disease - severe CHF - Sig CV risk
28
Side effects of incretin enhancers
hypoglycemia weight gain persistent postprandial hyperglycemia (their main effect is enhance insulin secretion and suppress glucagon secretion)
29
GIP-1 receptors are expressed in ____ and GLP-1 receptors are expressed in _____. Both are inactivated by ___.
GIP - pancreatic iiiiiiiislet GLP - brain and heart BOth are inactivated supah fast by DPP-4
30
GIP is produced in ______ GLP-1 is produced in _____ cells
Both are incretins: GIP-1 intestinal K cells in duodenum GLP-1 - intestinal L cells in distal ileum and colon
31
*GLP-1 controls:
made by L cells, act on receptors in brain and heart - effects: controls blood glucose, and CNS satiety
32
GIP controls:
Made by K cells , act on rcptrs in pancreatic iiislets - secreted after nutrient ingestion - not effective in T2D due to insulin resistance
33
When should you not use GLP-1
pts with active pancreatitis, hx of pancreatitis, pancreatic carcinoma
34
DPP-4 inhibitors
"gliptins" inhibit endogenous DPP-4 activity for 24 hrs - leads to 2-3 higher circulation of active endogenous GLP-1 and GIP
35
Adverse effects of DPP-4
nasopharyngitis | headache
36
Drugs that induce weight loss
GLP-1 receptor agonist Amylin analog (pramlintide) SGLT-2
37
Drugs that induce weight gain
sulfonylureas
38
weight neutral insulin drugs
metformin | DPP-4
39
Amylin action
- inhibits gastric emptying + glucagon secretion acutely, | - reduces short term food intake
40
SGLT-2 inhibitors
SGLT-2 is responsible for reabsorption of glucose in prox renal tubule - normally reabsorbs 99% of 180g of glucose. Stop that shit, stop reabsorbing and start excreting it, and reduce circulating glucose levels
41
DCCT
first large RCT that showed that intensive blood glucose control lead to reduced risk of development/progression of microvascular complications in T1D - follow up: legacy effect